Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
Source:
techcrunch
September 23, 2026 · 12:31
From the publisher
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
The original article opens on the publisher's website.
More from General
View topic →Epstein’s Accountant and Lawyer Are Said to Be Under Federal Investigation
nytimes
Sep 23, 2026 · 17:34
U.S.-China trade truce extended for two months, Bessent says, as Xi begins state visit
cnbc
Sep 23, 2026 · 16:59
Meta is trying VR glasses (again), this time with more IMAX
techcrunch
Sep 23, 2026 · 16:47
Diller abandons $18bn takeover bid for MGM Resorts
financialTimes
Sep 23, 2026 · 16:47
Meta introduces camera-free AI glasses
techcrunch
Sep 23, 2026 · 16:39